Terns Pharmaceuticals to Participate in Guggenheim Healthcare Talks 2023 Oncology Conference

Rhea-AI Summary

Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage biopharmaceutical company, announced its participation in a fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference on February 9, 2023, at 10:10 a.m. ET. The event will focus on Terns' innovative small-molecule product candidates aimed at addressing serious diseases such as oncology, obesity, and non-alcoholic steatohepatitis (NASH).

Additionally, a live audio webcast of the event will be accessible on the investor relations page of Terns' website, with a replay available for 30 days post-event.

FOSTER CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that management will participate in a fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference on Thursday, February 9, 2023 at 10:10 a.m. ET.

A live audio webcast of the event will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcast will be archived on Terns’ website for 30 days following the event.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and NASH. Terns’ pipeline includes four clinical stage development programs including an allosteric BCR-ABL inhibitor, a THR-β agonist, an FXR agonist, a VAP-1 inhibitor, and preclinical small-molecule GLP-1 receptor agonist and GIPR modulator programs. For more information, please visit: www.ternspharma.com.

Contacts for Terns

Investors
Justin Ng
investors@ternspharma.com

Media
Jenna Urban
Berry & Company Public Relations
media@ternspharma.com

FAQ

What is the date and time of Terns Pharmaceuticals' fireside chat at the Guggenheim Healthcare Talks 2023 Oncology Conference?

Terns Pharmaceuticals' fireside chat is scheduled for February 9, 2023, at 10:10 a.m. ET.

Where can I watch the Terns Pharmaceuticals fireside chat live?

The live audio webcast of the Terns Pharmaceuticals fireside chat will be available on their investor relations page at their official website.

What diseases is Terns Pharmaceuticals focused on treating?

Terns Pharmaceuticals is developing therapies for serious diseases including oncology, obesity, and non-alcoholic steatohepatitis (NASH).

How long will the webcast of Terns Pharmaceuticals' event be available for replay?

The replay of the webcast will be archived on Terns Pharmaceuticals’ website for 30 days following the event.

What is Terns Pharmaceuticals' stock symbol?

Terns Pharmaceuticals is traded under the stock symbol TERN on Nasdaq.